Paige AI

Paige develops AI to assist pathologists in cancer diagnosis. Its flagship product, Paige Prostate, is FDA-approved to help detect prostate cancer in biopsy slides. The AI analyzes whole slide images, highlights suspicious regions, and provides a confidence score for malignancy. The system is trained on millions of annotated slides and can catch subtle patterns that human reviewers might miss, especially in high-volume settings. It's designed as an augmentation tool — the pathologist makes the final call, but Paige acts as a second set of eyes. Studies show it reduces false negatives by 7-10%. Limitations include the need for high-quality digital slides and the fact that it's currently approved only for specific cancer types. Integration with existing lab workflows requires significant IT investment.